ENTRY       578               CDS       T01001
NAME        BAK1, BAK, BAK-LIKE, BCL2L7, CDN1
DEFINITION  (RefSeq) BCL2 antagonist/killer 1
ORTHOLOGY   K14021  Bcl-2 homologous antagonist/killer
ORGANISM    hsa  Homo sapiens (human)
PATHWAY     hsa01524  Platinum drug resistance
            hsa04141  Protein processing in endoplasmic reticulum
            hsa04210  Apoptosis
            hsa04215  Apoptosis - multiple species
            hsa05165  Human papillomavirus infection
            hsa05167  Kaposi's sarcoma-associated herpesvirus infection
            hsa05202  Transcriptional misregulation in cancer
            hsa05203  Viral carcinogenesis
            hsa05206  MicroRNAs in cancer
            hsa05210  Colorectal cancer
            hsa05212  Pancreatic cancer
            hsa05213  Endometrial cancer
            hsa05214  Glioma
            hsa05216  Thyroid cancer
            hsa05217  Basal cell carcinoma
            hsa05218  Melanoma
            hsa05220  Chronic myeloid leukemia
            hsa05222  Small cell lung cancer
            hsa05223  Non-small cell lung cancer
            hsa05224  Breast cancer
BRITE       KEGG Orthology (KO) [BR:hsa00001]
             Genetic Information Processing
              Folding, sorting and degradation
               04141 Protein processing in endoplasmic reticulum
                578 (BAK1)
             Cellular Processes
              Cell growth and death
               04210 Apoptosis
                578 (BAK1)
               04215 Apoptosis - multiple species
                578 (BAK1)
             Human Diseases
              Cancers
               05202 Transcriptional misregulation in cancers
                578 (BAK1)
               05206 MicroRNAs in cancer
                578 (BAK1)
               05203 Viral carcinogenesis
                578 (BAK1)
               05210 Colorectal cancer
                578 (BAK1)
               05212 Pancreatic cancer
                578 (BAK1)
               05214 Glioma
                578 (BAK1)
               05216 Thyroid cancer
                578 (BAK1)
               05220 Chronic myeloid leukemia
                578 (BAK1)
               05217 Basal cell carcinoma
                578 (BAK1)
               05218 Melanoma
                578 (BAK1)
               05213 Endometrial cancer
                578 (BAK1)
               05224 Breast cancer
                578 (BAK1)
               05222 Small cell lung cancer
                578 (BAK1)
               05223 Non-small cell lung cancer
                578 (BAK1)
              Infectious diseases
               05167 Kaposi's sarcoma-associated herpesvirus infection
                578 (BAK1)
               05165 Human papillomavirus infection
                578 (BAK1)
              Drug resistance
               01524 Platinum drug resistance
                578 (BAK1)
            Mitochondrial biogenesis [BR:hsa03029]
             Mitochondrial quality control factors
              Mitochondrial dynamics
               Fission and Fusion factors
                578 (BAK1)
            Transporters [BR:hsa02000]
             Other Transporters
              Pores ion channels [TC:1]
               578 (BAK1)
POSITION    6p21.31
MOTIF       Pfam: Bcl-2 Bcl-2_3
DBLINKS     NCBI-GeneID: 578
            NCBI-ProteinID: NP_001179
            OMIM: 600516
            HGNC: 949
            Ensembl: ENSG00000030110
            Vega: OTTHUMG00000014530
            Pharos: Q16611(Tbio)
            UniProt: Q16611 A0A0S2Z391
STRUCTURE   PDB: 2IMS 5FMI 2IMT 5FMK 2XPX 4UF1 2JBY 2YV6 5AJK 3QBR 4U2U
                 4D2L 2M5B 2JCN
AASEQ       211
            MASGQGPGPPRQECGEPALPSASEEQVAQDTEEVFRSYVFYRHQQEQEAEGVAAPADPEM
            VTLPLQPSSTMGQVGRQLAIIGDDINRRYDSEFQTMLQHLQPTAENAYEYFTKIATSLFE
            SGINWGRVVALLGFGYRLALHVYQHGLTGFLGQVTRFVVDFMLHHCIARWIAQRGGWVAA
            LNLGNGPILNVLVVLGVVLLGQFVVRRFFKS
NTSEQ       636
            atggcttcggggcaaggcccaggtcctcccaggcaggagtgcggagagcctgccctgccc
            tctgcttctgaggagcaggtagcccaggacacagaggaggttttccgcagctacgttttt
            taccgccatcagcaggaacaggaggctgaaggggtggctgcccctgccgacccagagatg
            gtcaccttacctctgcaacctagcagcaccatggggcaggtgggacggcagctcgccatc
            atcggggacgacatcaaccgacgctatgactcagagttccagaccatgttgcagcacctg
            cagcccacggcagagaatgcctatgagtacttcaccaagattgccaccagcctgtttgag
            agtggcatcaattggggccgtgtggtggctcttctgggcttcggctaccgtctggcccta
            cacgtctaccagcatggcctgactggcttcctaggccaggtgacccgcttcgtggtcgac
            ttcatgctgcatcactgcattgcccggtggattgcacagaggggtggctgggtggcagcc
            ctgaacttgggcaatggtcccatcctgaacgtgctggtggttctgggtgtggttctgttg
            ggccagtttgtggtacgaagattcttcaaatcatga
///
